| Acute promyelocytic leukemia, a malignancy of the | | | | from new types of AML based on morphologic |
| ivory marrow in which there is an inadequacy of old | | | | testing of an ivory marrow biopsy or aspirate. |
| blood cells in the myeloid cable of cells and a surplus | | | | Definitive diagnosis requires examination for the |
| of immature cells called promyelocytes. Acute | | | | RARá fusion gene. The handling of APL differs |
| promyelocytic leukemia is a subtype of intense | | | | from that for all new forms of AML. Most intense |
| myelogenous leukemia, a cancer of the blood and | | | | promyelocytic leukemia patients are now treated |
| ivory marrow. The signs and symptoms particular to | | | | with all-trans retinoic acid. All-trans retinoic acid |
| APL outcome from a shortfall of natural blood cells | | | | (ATRA) is a kind of differentiation therapy. It can |
| payable to crowding out of natural blood | | | | cause a comprehensive absolution in most patients |
| cell-producing ivory marrow by the leukemia cells. In | | | | with APL by causing the APL-blasts to grow. ATRA |
| Acute promyelocytic leukemia, there is an irregular | | | | is typically combined with anthracycline based |
| accretion of immature granulocytes called | | | | chemotherapy resulting in a clinical absolution in |
| promyelocytes. The disease is characterized by a | | | | roughly 90% of patients. ATRA therapy is associated |
| chromosomal translocation involving the retinoic acidic | | | | with the unusual position consequence of retinoic |
| receptor alpha gene and is unusual from new forms | | | | acidic syndrome. This is associated with the growth |
| of AML in its responsiveness to all trans retinoic acidic | | | | of dyspnea, fever, weight increase, incidental edema |
| therapy. | | | | and is treated with dexamethasone. |
| Acute promyelocytic leukemia is normally associated | | | | The prospect for acute promyelocytic leukemia |
| with a shortfall of natural light-colored blood cells (a | | | | depends on a number of factors including the white |
| circumstance called leukopenia) and, in specific, overly | | | | blood cell count at the time of diagnosis, etc. |
| few old granulocytes. This results in a high danger of | | | | Treatment options for patients with relapsed disease |
| infections. The peak incidence of APL is in | | | | include arsenic trioxide and allogeneic stem cell |
| inexperienced adults. APL is considered a character of | | | | transplant. Bone marrow transplantation may be |
| AML and is classified as the M3 variation of AML in | | | | successful in achieving a cure, but it is an option for |
| the internationally accepted french american british | | | | only a fraction of the younger relapsed patients. |
| classification. Signs and symptoms of intense | | | | Stem cell transplant is a method of giving |
| promyelocytic leukemia are related to new forms of | | | | chemotherapy and replacing blood-forming cells that |
| intense promyelocytic leukemia. Symptoms include | | | | are abnormal or destroyed by the cancer treatment. |
| weight departure or departure of appetite, shortness | | | | Stem cells are removed from the blood or bone |
| of breather with exertion, fever, tiredness, anemia, | | | | marrow of the patient or a donor and are frozen and |
| simple bruising or bleeding, petechiae, ivory pain and | | | | stored. Arsenic trioxide is the standard of care for |
| multilateral pain and relentless or regular infections. | | | | APL patients whose disease returns after or does |
| Acute promyelocytic leukemia can be distinguished | | | | not respond to initial treatment. |